Latest
The day's market news, with the argument attached
New notes every trading day on earnings, policy and market structure. Each one opens with the conclusion, then the evidence, then the companies it hits.
2026-07-18

Skyroot's First Private Orbital Rocket Turns India Into a New Launch-Provider Market
The Vikram-1 launch is more than a national milestone. It shows that India has crossed from a government-led space program into a private launch market, which matters for launch pricing, satellite deployment, and the long-term economics of commercial space.

The SOX Bear Market Is Not the End of AI, It Is the Start of a Capital-Discipline Regime
When the Philadelphia Semiconductor Index drops more than 20% from its high, the market is not saying AI demand vanished. It is saying the cost of owning the AI supply chain is now high enough that only the cleanest cash converters deserve a premium.

The SOX Bear Market Is Splitting AI Toll Collectors From AI Beta
When the semiconductor index falls into bear-market territory, the market is not dumping AI. It is sorting the AI stack into companies that toll the buildout and companies that are still being priced like pure beta.

SpaceX Scrubbed Starship Flight 13, and Launch Reliability Is Now the Real Valuation Test
The abort of Starship Flight 13 matters because the market is no longer valuing SpaceX only on ambition. It is valuing the company on whether the launch system can become reliable enough to support Starlink, NASA, and a much larger future launch cadence.
2026-07-17

Alphabet's Gemini 3.5 Delay Turns AI Leadership Into a Readiness Test
Google's months-long delay of Gemini 3.5 Pro is more than a product hiccup. It shows that in the current AI cycle, model readiness, coding performance, and developer trust matter as much as training scale, and the stock is starting to price that reality.

Chevron's Iraq Pipeline Push Turns Hormuz Risk Into a Midstream Re-Routing Trade
New Iraq agreements worth roughly $60 billion do more than add barrels. They signal that the market is starting to price alternative export routes, which changes the value of Chevron, ConocoPhillips, and the entire Gulf energy infrastructure stack.

CXMT's $8.6B IPO Turns China's DRAM Catch-Up Into a Direct Challenge to Micron
China's ChangXin Memory Technologies is using a blockbuster IPO to turn AI demand into domestic DRAM capacity. That is not just a China story; it is a direct pricing challenge for Micron, SK Hynix, and Samsung Electronics.

Fifth Third's Comerica Deal Turns Regional Bank M&A Into an Expense Discipline Test
Fifth Third's second-quarter print shows how bank M&A is being judged now: not just by revenue lift, but by whether the combined platform can absorb higher technology, compensation, and integration costs without losing operating leverage.

South Korea's ETF Crackdown Proves the AI Chip Rally Had Become a Leverage Product
South Korea's move to suspend new single-stock leveraged ETF listings is not just a retail-protection headline. It is a market-structure admission that the AI chip rally had become a leverage trade layered on top of a real memory upcycle.

Kuwait's Desalination Strike Makes Gulf Utilities the Hidden Front Line of the Oil Shock
An Iranian strike on Kuwait's water-and-power infrastructure turns a crude-price headline into a utility and inflation problem. The deeper read is that Gulf desalination, not just shipping lanes, is now part of the market's geopolitical risk premium.

Moonshot AI's Kimi K3 Turns the Chip Selloff Into a Margin Test for Nvidia, Broadcom, and Micron
The latest semis drawdown is not only about one Chinese model launch. It is a repricing of how much margin the AI stack can still support when benchmark pressure, export-control risk, and crowded positioning all hit at once.

Netflix's Slower Q3 Guide and Less Disclosure Turn Growth Into a Trust Problem
Netflix still grew in Q2, but the market is now punishing slower guidance and less visibility at the same time. That is a multiple problem as much as it is a revenue problem.

Netflix's Q2 Beat Didn't Save the Stock Because the Growth Slope Reset
Netflix posted a healthy Q2 with $12.56 billion of revenue and an EPS beat, but investors cared more about the narrowed 2026 revenue range, the 12% Q3 growth guide, and how the business is shifting toward ads, live events, and engagement quality.

Nvidia's Asia White-List Shrinkage Turns Export Controls Into a Distribution Moat
By cutting the number of authorized Asian buyers by more than half, Nvidia is making compliance part of the supply chain. That sounds bureaucratic, but it is actually a moat: fewer customers, tighter verification, and a more controllable route to China.

TSMC's Record Earnings Selloff Exposes the Three Fault Lines the AI Trade Can No Longer Ignore
TSMC delivered a record quarter on July 16, 2026, but the stock still sold off. That disconnect is the story: the AI semiconductor cycle is still strong, yet the market is now pricing margin compression, higher capex, and a broader repricing of AI infrastructure risk.

UnitedHealth's Guidance Raise Turns the Dow's Defensive Engine Back On
UnitedHealth's strong quarter matters because it showed that medical-cost control can still drive both earnings and index support. In a week when tech was weak, that is exactly the kind of defensive ballast the Dow needs.

The U.S. Chip Selloff Shows the AI Trade Is Being Repriced on Duration, Not Just Earnings
Even after strong results from TSMC, the market started selling the names that had benefited most from the AI spend cycle. That is a duration reset, not an earnings collapse, and it changes how investors should size the entire semiconductor basket.

Wall Street's Red-Hot Trading Quarter Is Really an Asia Volatility Trade
The bank earnings boom is bigger than a rate story. It is a volatility story, and increasingly an Asia story, with AI-chip flows, IPOs, and cross-border risk all feeding the same trading machine.
2026-07-16

Abbott Labs Q2 2026 Beat + EPS Guide Raised + 410th Consecutive Quarterly Dividend - The Cleanest Single Defensive Growth Anchor in Med-Tech
Abbott reported Q2 2026 results on July 16, 2026, beating consensus with total sales of $12.6B (+13.0% reported, +4.8% organic), adjusted EPS of $1.31 (vs ~$1.27 consensus), and raised full-year 2026 EPS guidance to $5.45-5.60 (from $5.38-5.58). The company also declared its 410th consecutive quarterly dividend and returned $2.1B to shareholders in Q2. Abbott is the cleanest single defensive growth anchor in med-tech with a multi-decade dividend growth record.

Alcoa Missed the Bar, But the Real Signal Is Supply Discipline: Pinjarra, South32, and Hormuz Are Repricing Aluminum
Alcoa reported Q2 2026 adjusted EPS of $2.12 and revenue of $3.97B, both below expectations, while cutting alumina production guidance after setbacks at the Pinjarra refinery. The stock slid despite better year-over-year profitability because the market is now focused on supply discipline, capital intensity, and how much of the aluminum chain is being shaped by Middle East risk and a major South32 acquisition.
What to expect
Evidence-first notes with a visible point of view.
This section collects sharp takes on earnings, shareholder meetings, and market structure. Each new piece should make the thesis, the facts, and the implications obvious within the first few screens.
Expect direct analysis, not generic commentary.
Expect the data to be explicit and the argument to be easy to follow.
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer